Published in Thromb Haemost on February 19, 2010
Divergent phenotype of rat thoracic and abdominal perivascular adipose tissues. Am J Physiol Regul Integr Comp Physiol (2013) 1.08
Vascular endothelial growth factor receptor-2 couples cyclo-oxygenase-2 with pro-angiogenic actions of leptin on human endothelial cells. PLoS One (2011) 1.02
Adipose tissue and vascular phenotypic modulation by voluntary physical activity and dietary restriction in obese insulin-resistant OLETF rats. Am J Physiol Regul Integr Comp Physiol (2014) 0.95
Differential effects of leptin and adiponectin in endothelial angiogenesis. J Diabetes Res (2015) 0.89
Gal-geun-dang-gwi-tang improves diabetic vascular complication in apolipoprotein E KO mice fed a western diet. BMC Complement Altern Med (2014) 0.75
Circulating microRNAs in patients with coronary artery disease. Circ Res (2010) 6.28
Enoxaparin versus unfractionated heparin in elective percutaneous coronary intervention. N Engl J Med (2006) 5.07
A key role of leptin in the control of regulatory T cell proliferation. Immunity (2007) 3.71
An oscillatory switch in mTOR kinase activity sets regulatory T cell responsiveness. Immunity (2010) 2.71
Does carotid intima-media thickness regression predict reduction of cardiovascular events? A meta-analysis of 41 randomized trials. J Am Coll Cardiol (2010) 2.56
Vascular structures in skin tumors: a dermoscopy study. Arch Dermatol (2004) 2.51
Endothelial dysfunction and cardiovascular risk prediction in peripheral arterial disease: additive value of flow-mediated dilation to ankle-brachial pressure index. Circulation (2003) 2.41
Administration of a loading dose has no additive effect on platelet aggregation during the switch from ongoing clopidogrel treatment to ticagrelor in patients with acute coronary syndrome. Circ Cardiovasc Interv (2014) 1.97
Dermoscopy improves accuracy of primary care physicians to triage lesions suggestive of skin cancer. J Clin Oncol (2006) 1.81
Impact of gender in primary prevention of coronary heart disease with statin therapy: a meta-analysis. Int J Cardiol (2008) 1.76
Relationship between oxidative stress, lipid peroxidation, and ultrastructural damage in patients with coronary artery disease undergoing cardioplegic arrest/reperfusion. Cardiovasc Res (2006) 1.75
Physical training increases eNOS vascular expression and activity and reduces restenosis after balloon angioplasty or arterial stenting in rats. Circ Res (2002) 1.67
C-reactive protein induces tissue factor expression and promotes smooth muscle and endothelial cell proliferation. Cardiovasc Res (2005) 1.67
Effects of Ile164 polymorphism of beta2-adrenergic receptor gene on coronary artery disease. J Am Coll Cardiol (2008) 1.65
Calcium channel blockers and cardiovascular outcomes: a meta-analysis of 175,634 patients. J Hypertens (2009) 1.63
Myeloperoxidase, but not C-reactive protein, predicts cardiovascular risk in peripheral arterial disease. Eur Heart J (2007) 1.62
Ischemic neoangiogenesis enhanced by beta2-adrenergic receptor overexpression: a novel role for the endothelial adrenergic system. Circ Res (2005) 1.57
Enoxaparin versus unfractionated heparin in elective percutaneous coronary intervention 1-year results from the STEEPLE (SafeTy and efficacy of enoxaparin in percutaneous coronary intervention patients, an international randomized evaluation) trial. JACC Cardiovasc Interv (2009) 1.56
Induction of mitogen-activated protein kinases is proportional to the amount of pressure overload. Hypertension (2009) 1.53
Hemodynamic determinants of exercise-induced abnormal blood pressure response in hypertrophic cardiomyopathy. J Am Coll Cardiol (2002) 1.48
Myocardial collagen turnover in hypertrophic cardiomyopathy. Circulation (2003) 1.48
Inflammation in peripheral artery disease. Circulation (2010) 1.47
Coronary stenting versus balloon angioplasty for acute myocardial infarction: a meta-regression analysis of randomized trials. Int J Cardiol (2007) 1.46
The adipokine visfatin induces tissue factor expression in human coronary artery endothelial cells: another piece in the adipokines puzzle. Thromb Res (2012) 1.45
Clinical impact of sirolimus-eluting stent in ST-segment elevation myocardial infarction: a meta-analysis of randomized clinical trials. Catheter Cardiovasc Interv (2009) 1.43
[Novel concepts in beta-adrenergic receptor signaling: therapeutic options for heart failure]. G Ital Cardiol (Rome) (2010) 1.40
Relationship between contractile reserve, Tl-201 uptake, and collateral angiographic circulation in collateral-dependent myocardium: implications regarding the evaluation of myocardial viability. J Nucl Cardiol (2003) 1.39
[Assessment of quality of life in patients with peripheral arterial disease: a problem left ahead]. G Ital Cardiol (Rome) (2009) 1.37
[European National Society cardiovascular journals. Background, rationale and mission statement of the "editors' club"]. Rev Esp Cardiol (2008) 1.26
Endothelial dysfunction: a key to the pathophysiology and natural history of peripheral arterial disease? Atherosclerosis (2008) 1.21
Insulation defects of thin high-voltage ICD leads: an underestimated problem? J Cardiovasc Electrophysiol (2011) 1.19
Role of beta2 adrenergic receptors in human atherosclerotic coronary arteries. Circulation (2005) 1.15
The GPIIIA PlA2 polymorphism is associated with an increased risk of cardiovascular adverse events. BMC Cardiovasc Disord (2010) 1.12
In vivo role of different domains and of phosphorylation in the transcription factor Nkx2-1. BMC Dev Biol (2011) 1.10
AKAP121 downregulation impairs protective cAMP signals, promotes mitochondrial dysfunction, and increases oxidative stress. Cardiovasc Res (2010) 1.09
Aspiration thrombectomy: an easily forgiven "latecomer". J Am Coll Cardiol (2014) 1.09
Determinants of atrial fibrillation development in patients with hypertrophic cardiomyopathy. Am J Cardiol (2004) 1.08
Intracoronary versus intravenous abciximab bolus administration. J Am Coll Cardiol (2014) 1.08
Patients with acute coronary syndrome show oligoclonal T-cell recruitment within unstable plaque: evidence for a local, intracoronary immunologic mechanism. Circulation (2006) 1.07
Leptin-induced mTOR activation defines a specific molecular and transcriptional signature controlling CD4+ effector T cell responses. J Immunol (2012) 1.07
Hydroxymethylglutaryl coenzyme A reductase inhibitor simvastatin prevents cardiac hypertrophy induced by pressure overload and inhibits p21ras activation. Circulation (2002) 1.06
FK506 can activate transforming growth factor-beta signalling in vascular smooth muscle cells and promote proliferation. Cardiovasc Res (2008) 1.05
Omega-3 polyunsaturated fatty acid in peripheral arterial disease: effect on lipid pattern, disease severity, inflammation profile, and endothelial function. Clin Nutr (2008) 1.03
Abnormal blood-pressure response to exercise and oxygen consumption in patients with hypertrophic cardiomyopathy. J Nucl Cardiol (2007) 1.02
EGFR trans-activation by urotensin II receptor is mediated by β-arrestin recruitment and confers cardioprotection in pressure overload-induced cardiac hypertrophy. Basic Res Cardiol (2011) 1.02
Unusual association between acrokeratosis verruciformis of Hopf and multiple keratoacanthomas. Successful therapy with acitretin. J Dtsch Dermatol Ges (2004) 1.02
Myocardial fibrosis and diastolic dysfunction in patients on chronic haemodialysis. Nephrol Dial Transplant (2010) 1.01
Oleuropein prevents oxidative myocardial injury induced by ischemia and reperfusion. J Nutr Biochem (2004) 1.01
Bariatric surgery and diabetes remission: sleeve gastrectomy or mini-gastric bypass? World J Gastroenterol (2013) 1.00
Rat carotid artery dilation by PTCA balloon catheter induces neointima formation in presence of IEL rupture. Am J Physiol Heart Circ Physiol (2002) 0.98
Prevalence, risk factors and cardiovascular comorbidity of symptomatic peripheral arterial disease in Italy. Atherosclerosis (2004) 0.97
Cyclic peptides from a Ruegeria strain of bacteria associated with the sponge Suberites domuncula. J Nat Prod (2004) 0.96
Cardiotoxic effects, or lack thereof, of anti-ErbB2 immunoagents. FASEB J (2009) 0.95
Relation of brachial artery flow-mediated vasodilation to significant coronary artery disease in patients with peripheral arterial disease. Am J Cardiol (2005) 0.95
Reactive oxygen species and antioxidants in the pathophysiology of cardiovascular disease: does the actual knowledge justify a clinical approach? Curr Vasc Pharmacol (2010) 0.94
Aging exacerbates negative remodeling and impairs endothelial regeneration after balloon injury. Am J Physiol Heart Circ Physiol (2004) 0.94
The microRNA-processing enzyme Dicer is essential for thyroid function. PLoS One (2011) 0.94
Thoracic aortic emergencies: impact of endovascular surgery. Ann Thorac Surg (2004) 0.93
Myocardial texture in hypertrophic cardiomyopathy. J Am Soc Echocardiogr (2007) 0.93
Left ventricular remodelling in patients with moderate systolic dysfunction after myocardial infarction: favourable effects of exercise training and predictive role of N-terminal pro-brain natriuretic peptide. Eur J Cardiovasc Prev Rehabil (2008) 0.92
Neopterin: from forgotten biomarker to leading actor in cardiovascular pathophysiology. Curr Vasc Pharmacol (2011) 0.92
Risk for permanent pacemaker after transcatheter aortic valve implantation: a comprehensive analysis of the literature. J Cardiovasc Electrophysiol (2011) 0.91
Metabolic syndrome in peripheral arterial disease: relationship with severity of peripheral circulatory insufficiency, inflammatory status, and cardiovascular comorbidity. J Vasc Surg (2006) 0.90
Leukocyte count in peripheral arterial disease: A simple, reliable, inexpensive approach to cardiovascular risk prediction. Atherosclerosis (2009) 0.90
Computed tomography findings of pneumatosis and portomesenteric venous gas in acute bowel ischemia. World J Gastroenterol (2013) 0.89
Involvement of tissue factor pathway inhibitor in the coronary circulation of patients with acute coronary syndromes. Circulation (2003) 0.89
Intracellular route and mechanism of action of ERB-hRNase, a human anti-ErbB2 anticancer immunoagent. FEBS Lett (2007) 0.89
Adjunctive mechanical devices to prevent distal embolization in patients undergoing mechanical revascularization for acute myocardial infarction: a meta-analysis of randomized trials. Am Heart J (2007) 0.89
The STS score is the strongest predictor of long-term survival following transcatheter aortic valve implantation, whereas access route (transapical versus transfemoral) has no predictive value beyond the periprocedural phase. Interact Cardiovasc Thorac Surg (2013) 0.89
Multicentre experience with MGuard net protective stent in ST-elevation myocardial infarction: safety, feasibility, and impact on myocardial reperfusion. Catheter Cardiovasc Interv (2010) 0.89
Wernicke encephalopathy in subjects undergoing restrictive weight loss surgery: a systematic review of literature data. Eur Eat Disord Rev (2014) 0.88
Tissue factor binding of activated factor VII triggers smooth muscle cell proliferation via extracellular signal-regulated kinase activation. Circulation (2004) 0.88
Effects of successful percutaneous lower extremity revascularization on cardiovascular outcome in patients with peripheral arterial disease. Int J Cardiol (2012) 0.88
Prognostic significance of left atrial volume dilatation in patients with hypertrophic cardiomyopathy. J Am Soc Echocardiogr (2009) 0.87
Leptin stimulated C-reactive protein production by human coronary artery endothelial cells. J Vasc Res (2009) 0.87
Exocellular peptides from Antarctic psychrophile Pseudoalteromonas Haloplanktis. Mar Biotechnol (NY) (2005) 0.87
Femoral plaque echogenicity and cardiovascular risk in claudicants. JACC Cardiovasc Imaging (2012) 0.87
Safety and efficacy of barbed suture for gastrointestinal suture: a prospective and randomized study on obese patients undergoing gastric bypass. J Laparoendosc Adv Surg Tech A (2013) 0.87
Targeted inhibition of phosphoinositide 3-kinase activity as a novel strategy to normalize beta-adrenergic receptor function in heart failure. Vascul Pharmacol (2006) 0.86
A novel cyclopeptide from a bacterium associated with the marine sponge Ircinia muscarum. Z Naturforsch C (2003) 0.86
Cellular adhesion molecules and peripheral arterial disease. Vasc Med (2006) 0.86
Adhesion molecules and cardiovascular risk in peripheral arterial disease. Soluble vascular cell adhesion molecule-1 improves risk stratification. Thromb Haemost (2005) 0.86
Acute acalculous cholecystitis determining Mirizzi syndrome: case report and literature review. BMC Surg (2014) 0.86
Effect of drug-eluting stents in patients with acute ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention: a meta-analysis of randomised trials and an adjusted indirect comparison. EuroIntervention (2010) 0.85
Tissue factor is induced by resistin in human coronary artery endothelial cells by the NF-ĸB-dependent pathway. J Vasc Res (2010) 0.85
Coronary angioplasty with stenting for acute coronary syndrome in patients with isolated single coronary artery: a report of two cases. J Cardiovasc Med (Hagerstown) (2009) 0.85
Avarol inhibits TNF-alpha generation and NF-kappaB activation in human cells and in animal models. Life Sci (2007) 0.85
Intracranial gene delivery of LV-NAGLU vector corrects neuropathology in murine MPS IIIB. Am J Med Genet A (2009) 0.85
Different vascular response to concurrent implantation of sirolimus- and zotarolimus-eluting stents in the same vessel. Heart Vessels (2009) 0.84